Medtronic Plc Stock Current Ratio
MDTC34 Stock | BRL 245.59 0.40 0.16% |
Medtronic plc fundamentals help investors to digest information that contributes to Medtronic Plc's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic Plc stock.
Medtronic |
Medtronic plc Company Current Ratio Analysis
Medtronic Plc's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Medtronic Plc Current Ratio | 2.89 X |
Most of Medtronic Plc's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
In accordance with the recently published financial statements, Medtronic plc has a Current Ratio of 2.89 times. This indicator is about the same for the Healthcare average (which is currently at 2.91) sector and 15.0% lower than that of the Medical Devices industry. The current ratio for all Brazil stocks is 33.8% lower than that of the firm.
Medtronic Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic Plc's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic Plc could also be used in its relative valuation, which is a method of valuing Medtronic Plc by comparing valuation metrics of similar companies.Medtronic Plc is considered to be number one stock in current ratio category among its peers.
Medtronic Fundamentals
Return On Equity | 0.0833 | |||
Return On Asset | 0.0422 | |||
Profit Margin | 0.14 % | |||
Operating Margin | 0.20 % | |||
Current Valuation | 625.84 B | |||
Shares Outstanding | 2.66 B | |||
Price To Earning | 52.06 X | |||
Price To Book | 2.03 X | |||
Price To Sales | 18.03 X | |||
Revenue | 31.69 B | |||
Gross Profit | 21.71 B | |||
EBITDA | 8.78 B | |||
Net Income | 5.04 B | |||
Cash And Equivalents | 10.6 B | |||
Cash Per Share | 3.94 X | |||
Total Debt | 20.32 B | |||
Debt To Equity | 0.50 % | |||
Current Ratio | 2.89 X | |||
Book Value Per Share | 19.50 X | |||
Cash Flow From Operations | 7.35 B | |||
Earnings Per Share | 8.13 X | |||
Price To Earnings To Growth | 3.05 X | |||
Number Of Employees | 95 K | |||
Beta | 0.73 | |||
Market Capitalization | 589.18 B | |||
Total Asset | 90.98 B | |||
Z Score | 17.4 | |||
Annual Yield | 0.03 % | |||
Net Asset | 90.98 B | |||
Last Dividend Paid | 2.62 |
About Medtronic Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.